NOVEL EGFR/PI3K DUAL-TARGETING NANOPARTICLES INDUCE IMMUNOGENIC CELL DEATH IN BLADDER CANCER

被引：0
|
作者：
Zhu, Zheng [1 ]
Xue, Xiangdong [2 ]
Zhou, Gang [3 ]
Song, Zewen [4 ]
Li, Guoyin [5 ]
机构：
[1] Harvard Med Sch, West Roxbury, MA USA
[2] Shanghai Jiao Tong Univ, Shanghai, Peoples R China
[3] Fourth Millitary Med Univ, Xian, Peoples R China
[4] Cent South Univ, Changsha, Peoples R China
[5] Zhoukou Normal Univ, Zhoukou, Henan, Peoples R China
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.1358
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1358
引用
收藏
页码：A1409 / A1409
页数：1
相关论文
共 50 条
  • [41] Emerging strategies for targeting PI3K in gynecologic cancer
    Bregar, Amy J.
    Growdon, Whitfield B.
    GYNECOLOGIC ONCOLOGY, 2016, 140 (02) : 333 - 344
  • [42] PI3K targeting in breast cancer: the end of the beginning?
    Bachelot, Thomas
    Campone, Mario
    Tredan, Olivier
    LANCET ONCOLOGY, 2016, 17 (06): : 696 - 697
  • [43] Hypoxia Targeting Nanoparticles for Immunogenic Cell Death of Triple Negative Breast Cancer
    Bhise, Ketki
    Sau, Samaresh
    Rauf, Mohd
    Alzhrani, Rami
    Iyer, Arun
    FASEB JOURNAL, 2020, 34
  • [44] Discovery of novel and potent PARP/PI3K dual inhibitors for the treatment of cancer
    Wu, Zhengyang
    Bai, Ying
    Jin, Jiaming
    Jiang, Teng
    Shen, Hui
    Ju, Qiurong
    Zhu, Qihua
    Xu, Yungen
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 217
  • [45] Syringin as a novel therapeutic agent for renal cell carcinoma by targeting EGFR/PI3K/Akt pathway and enhancing sunitinib efficacy
    Chen, Zixuan
    Cheng, Sheng
    Xu, An
    Han, Chengtao
    Jia, Xing
    Liu, Min
    JOURNAL OF FUNCTIONAL FOODS, 2024, 123
  • [46] Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy
    Han, Beinan
    Lin, Xiaorong
    Hu, Hai
    TRANSLATIONAL BREAST CANCER RESEARCH, 2024, 5
  • [47] Achieving cancer cell death with PI3K/mTOR-targeted therapies
    Yea, Sung Su
    Fruman, David A.
    INOSITOL PHOSPHOLIPID SIGNALING IN PHYSIOLOGY AND DISEASE, 2013, 1280 : 15 - 18
  • [48] Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co-targeting EGFR and PI3K in cisplatin-resistant HNSCC
    Liao, Jipei
    Yang, Zejia
    Abarzarzin, Shirin
    Cullen, Kevin J.
    Dan, Hancai
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (05): : 1126 - 1135
  • [49] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
  • [50] Targeting EGFR and PI3K/mTOR pathways in glioblastoma: innovative therapeutic approaches
    Singh, Gursimran
    Rohit, Pankaj
    Kumar, Pankaj
    Aran, Khadga Raj
    MEDICAL ONCOLOGY, 2025, 42 (04)
12345